Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

View:
Post by ChaseAckland on Feb 11, 2021 12:33pm

HPV

This share price fluctuation / drop  just doesnt make any sense...fell into some bizzare rabbit hole of a stock alternate reality....
Am bullish on the ovarian cancer vaccine and COVID-T diagnostic, but having Papilocare in the US market is a major development.   There is a report by Fortune that the globsl HPV market is currently US$3.8billion and projected to reach $12.69billion by 2027, with 16.3% CAGR.  North America has largest share of HPV vaccines at $1.83Billion.  Huge market potential!  And with Papilocare, an ovarian cancer vaccine ramping up for compassionate use in the EU, and  a HPV vaccine and cervical cancer vaccine now in development w/ Procare, these guys are getting set up as a dominant player in gynecological oncology.
Comment by Seaman on Feb 12, 2021 1:20am
Yes you've absolutely right! But what can we do to fight the short sellers as anon? Absolutely nothing. The only thing we can do, telling friends about this phantastic company and buying shares on this low price level! This price level could we have one week or so, not longer!
Comment by bomdrou99 on Feb 12, 2021 7:11am
We can clearly see the game of daytraders. They are going to start to buy back very soon and the price will go up quickly and a lot. I am less disappointed too, but I will not give in to the daytraders. My resistance to this little game will pay off very quickly. The news from the company is huge. It's time to buy.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities